Puig, N., & Alegre Amor, A. (2024). Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial.
Citação norma ChicagoPuig, Noemí, y Adrián Alegre Amor. Single-point and Kinetics of Peripheral Residual Disease By Mass Spectrometry to Predict Outcome in Patients With High-risk Smoldering Multiple Myeloma Included in the GEM-CESAR Trial. 2024.
Citação norma MLAPuig, Noemí, y Adrián Alegre Amor. Single-point and Kinetics of Peripheral Residual Disease By Mass Spectrometry to Predict Outcome in Patients With High-risk Smoldering Multiple Myeloma Included in the GEM-CESAR Trial. 2024.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.